Active transcutaneous bone conduction implant: audiological results in paediatric patients with bilateral microtia

Sofía Bravo-Torres1,2, Carolina Der-Mussa1,3, Eduardo Fuentes-López4,5

  • 1a Unidad de Otorrinolaringologia, Servicio de Cirugia , Hospital Dr. Luis Calvo Mackenna , Santiago , Chile.

Insights

The Bonebridge™ implant significantly improved hearing and word recognition in children with congenital conductive hearing loss. This active bone conduction implant offers functional gain for pediatric patients.

Area of Science:

  • Otolaryngology
  • Audiology
  • Biomedical Engineering

Background:

  • Conductive hearing loss in children can result from external ear malformations.
  • Bone conduction implants offer an alternative for hearing rehabilitation when conventional hearing aids are insufficient.

Purpose of the Study:

  • To evaluate the audiological outcomes of pediatric patients (<18 years) implanted with the Bonebridge™ active bone conduction implant.
  • To assess functional gain and word recognition improvements in this cohort.

Main Methods:

  • Retrospective case study design.
  • Analysis of medical records from patients who received the Bonebridge™ implant between 2014 and 2016 in Chile's public health sector.
  • Inclusion criteria: bilateral conductive hearing loss secondary to external ear malformations (N=15).

Main Results:

  • Average hearing threshold at one month post-activation was 25.2 dB.
  • Improved hearing thresholds compared to traditional bone conduction hearing aids, particularly between 0.5-4 kHz.
  • Significant increase in monosyllable word recognition observed during the adaptation period.

Conclusions:

  • The Bonebridge™ active bone conduction implant demonstrates efficacy in improving hearing thresholds.
  • Significant functional gain and enhanced word recognition were noted in pediatric patients with congenital conductive hearing loss.
Abstract

Related Concept Videos